机构

• 上海药物研究所 [109]

采集方式

• OAI收割 [109]

内容类型

• 期刊论文 [107]
• 会议论文 [2]

发表日期

• 2024 [4]
• 2023 [12]
• 2022 [12]
• 2021 [6]
• 2020 [7]
• 2019 [10]
• 更多

学科主题

• Chemistry [3]
• Pharmacolo... [3]
• Biochemist... [1]
• Oncology [1]

筛选

浏览/检索结果: 共109条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序题名升序题名降序作者升序作者降序发表日期升序发表日期降序 Biotransformation and disposition characteristics of HSK7653, a novel long-acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes 期刊论文  OAI收割 DIABETES OBESITY & METABOLISM, 2024, 页码: 9 作者:  Bian, Yi-cong;  Meng, Jian;  Hu, Tao;  Ma, Sheng;  Huang, Chen-rong   |  收藏  |  浏览/下载：0/0  |  提交时间：2024/05/22 HSK7653  long-acting dipeptidyl peptidase-4 inhibitor  mass balance  metabolism  pharmacokinetics  radiolabelled   Distinct roles of the extracellular surface residues of glucagon-like peptide-1 receptor in B-arrestin 1/2 signaling 期刊论文  OAI收割 EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 卷号: 968, 页码: 17 作者:  Lei, Saifei;  Meng, Qian;  Liu, Yanyun;  Liu, Qiaofeng;  Dai, Antao   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/05/22 GLP-1R  B-arrestin 1/2  Biased agonism  Bioluminescence resonance energy transfer  Proteomics profiling   Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner 期刊论文  OAI收割 METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 卷号: 152, 页码: 12 作者:  Meng, Meiyao;  Cao, Yuxiang;  Qiu, Jin;  Shan, Guangyu;  Wang, Yingwen   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/03/25 Triglyceride metabolism  ZNF638  Adipose tissue  Angptl8  Lipoprotein lipase   Quantitative proteomics reveals the protective effects of Yinchenzhufu decoction against cholestatic liver fibrosis in mice by inhibiting the PDGFRβ/PI3K/AKT pathway 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2024, 卷号: 15, 页码: 13 作者:  Meng, Qian;  Zhu, Hongwen;  Li, Yuanyuan;  Peng, Xiaotian;  Wang, Tianming   |  收藏  |  浏览/下载：2/0  |  提交时间：2024/05/07 Yinchenzhufu decoction  proteomics  cholestasis  liver fibrosis  PDGFR beta/PI3K/AKT   A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects 期刊论文  OAI收割 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 卷号: 191, 页码: 9 作者:  Yang, Xin-Mei;  Yang, Yang;  Yao, Bu-Fan;  Ye, Pan-Pan;  Xu, Yan   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/12/11 COVID-19  Simnotrelvir  Safety  Pharmacokinetics  Healthy subjects   Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines 期刊论文  OAI收割 BIOCHEMICAL PHARMACOLOGY, 2023, 卷号: 215, 页码: 14 作者:  Xu, Zhuo;  Wang, Hui;  Meng, Qian;  Ding, Yiluan;  Zhu, Mengying   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Otilonium Bromide  Deubiquitinase  USP28  Selective inhibitor   Discovery, SAR Study of GST Inhibitors from a Novel Quinazolin-4(1H)-one Focused DNA-Encoded Library 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 页码: 15 作者:  Wen, Xin;  Zhang, Minmin;  Duan, Zhiqiang;  Suo, Yanrui;  Lu, Weiwei   |  收藏  |  浏览/下载：33/0  |  提交时间：2023/10/17 Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease 期刊论文  OAI收割 PROTEIN EXPRESSION AND PURIFICATION, 2023, 卷号: 207, 页码: 106267 作者:  Qiao, Huarui;  Li, Lingyun;  Wang, Lu;  Yu, Haijun;  Hu, Fangzheng   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/03/27 SARS-CoV-2  Papain like protease (PLpro)  Nanobody  PLpro inhibitor   A procedure for producing an anti-AXL nanobody in E. coli 期刊论文  OAI收割 PROTEIN EXPRESSION AND PURIFICATION, 2023, 卷号: 207, 页码: 106268 作者:  Lan, Zhongyun;  Li, Lingyun;  Sun, Yili;  Meng, Xiangjing;  Shi, Zhenzhong   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/03/27 AXL  Nanobody  Expression  Purification   Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma 期刊论文  OAI收割 NATIONAL SCIENCE REVIEW, 2023, 卷号: 10, 期号: 8, 页码: 17 作者:  Zhu, Hongwen;  Lin, Youpei;  Lu, Dayun;  Wang, Shisheng;  Liu, Yuejia   |  收藏  |  浏览/下载：23/0  |  提交时间：2023/10/17 proteomics  hepatocellular carcinoma  normal tissue adjacent to tumor  heterogeneity